CERSNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
CERUS CORP
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 30, 2026
$2.22+0.04 (+1.83%)
Close on Oct 19, 2026
- Market cap
- $445.25M
- P/E (TTM)
- –
- Dividend yield
- –
CERUS CORP revenue by segment
By business segment
By product or service
| Revenue | Q2 26 | Q1 26 | Q4 25 | Q3 25 | Q2 25 | Q1 25 | Q4 24 | Q3 24 | Q2 24 | Q1 24 | Q4 23 | Q3 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Product | $57.44M | $53.66M | $57.75M | $52.70M | $52.45M | $43.24M | $50.81M | $46.02M | $45.08M | $38.37M | $46.77M | $39.77M | 100.0% | +9.5% |
| Government Contract | – | – | $6.83M | $7.54M | $7.68M | $5.61M | $5.94M | $4.64M | $5.44M | $5.03M | $6.57M | $7.48M | – | – |
By region
From the segment and revenue-disaggregation notes of Cerus's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.